A PHASE I/II, OPEN-LABEL, MULTI-COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CEVOSTAMAB IN PRIOR B CELL MATURATION ANTIGEN-EXPOSED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Is This Study For You?

Let's Get Started!

Details
Age
Adult
Locations

CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Daniel Sherbenou

Daniel Sherbenou

Study ID

Protocol Number: 22-0931

More information available at ClinicalTrials.gov: NCT05535244

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers